Active infection requiring intravenous (IV) antibiotics
Active infection requiring intravenous antibiotics within 1 week of study enrollment (day 1).
Active infection requiring intravenous antibiotics at cycle 1 day 1
Active systemic infection requiring intravenous antibiotics within 2 weeks of treatment start
Patients with any unstable medical issue (including cardiac issues as above, active treatment for symptomatic pulmonary embolism, cerebrovascular accident [CVA], renal or hepatic insufficiency, active infection/sepsis requiring intravenous [IV] antibiotics)
Ongoing or active infection; the requirement for intravenous (IV) antibiotics is considered active infection
Ongoing active infection; the requirement for intravenous (IV) antibiotics is considered active infection
Active infection (infection requiring intravenous antibiotics)
Active infection requiring intravenous (IV) antibiotics within 14 days before Day 1, Cycle 1
Active infection requiring intravenous antibiotics at week 1 day 1
Active serious infection not controlled by oral or intravenous antibiotics
Clinically significant active infection requiring intravenous antibiotics (=< 14 days prior to registration)
Active infection requiring intravenous antibiotics (must be completed prior to registration)
Infection requiring intravenous antibiotics that was completed < 1 week of study enrollment (day 1) with the exemption of prophylactic antibiotics for long line insertion or biopsy
Active infection (requiring oral or intravenous antibiotics or antiviral therapy).
Active serious infection not controlled by oral or intravenous antibiotics.
Patients with active systemic infections requiring intravenous antibiotics within 1 week prior to enrollment
Active infection requiring intravenous antibiotics (antibiotics should have been completed prior to registration)
Active serious infection not controlled by oral or intravenous antibiotics.
Active infection requiring intravenous (IV) antibiotics or other uncontrolled intercurrent illness requiring hospitalization.
Clinically significant active infection requiring intravenous antibiotics =< 14 days prior to registration
Any uncontrolled active systemic infection requiring intravenous (IV) antibiotics
Active infection requiring intravenous antibiotics
Evidence of ongoing or active infection requiring intravenous antibiotics;
Active infection requiring intravenous antibiotics within 7 days before enrollment
Active infection requiring intravenous antibiotics at the time of registration
Patients must be free of systemic infection requiring intravenous (IV) antibiotics at the time of registration; patients must be off IV antibiotics for at least 7 days prior to registration
Unstable systemic disease in the opinion of the treating physician, for example active infection requiring intravenous (IV) antibiotics
Serious active infection requiring intravenous (IV) antibiotics
Patients must be free of systemic infection requiring intravenous (IV) antibiotics at the time of registration; patients must be off IV antibiotics for at least 7 days prior to registration
Patients should be free of active infection requiring intravenous antibiotics
Active serious infection not controlled by oral or intravenous antibiotics
Patients must be free of systemic infection requiring intravenous (IV) antibiotics at the time of registration; patients must be off IV antibiotics for at least 7 days prior to registration
Active infection requiring oral or intravenous antibiotics
Patients with active chronic or current infections requiring oral or intravenous antibiotics are NOT eligible for enrollment to the study until resolution of the infection and completion of therapeutic antibiotics
Active clinically serious infection requiring intravenous antibiotics at the time of study entry (CTCAE Grade 2)
Active infection requiring intravenous (IV) antibiotics or other uncontrolled intercurrent illness requiring hospitalization.
Active infection requiring intravenous (IV) antibiotics or other uncontrolled intercurrent illness requiring hospitalization
Serious infection requiring treatment with intravenous antibiotics at the time of study entrance, or an infection requiring intravenous therapy within 7 days prior.
Serious infection requiring hospitalization or intravenous (IV) antibiotics within 14 days prior to enrollment
Active infection requiring intravenous antibiotics
At least 7 days beyond any infection requiring intravenous antibiotic use (Oral\n             antibiotics may be administered prophylactically as clinically indicated)
Patients have an active infection and require intravenous (IV) or oral antibiotics
Receipt of intravenous antibiotics for infection within 7 days prior to enrollment
Patients with active infection and requiring intravenous (IV) or oral antibiotics
Serious active infection requiring intravenous (i.v.) antibiotics at enrollment
Active systemic infections requiring intravenous antibiotics
Patients must not have uncontrolled active systemic infection requiring intravenous antibiotics
Patients with active systemic infection requiring intravenous antibiotics
Serious active infection requiring intravenous antibiotics and/or hospitalization at study entry
Any infection requiring ongoing intravenous antibiotics for management
Patient has evidence of a serious active infection (e.g., infection requiring treatment with intravenous antibiotics).
Active infection requiring intravenous (IV) antibiotics or other uncontrolled intercurrent illness requiring hospitalization
Active (acute or chronic) or uncontrolled severe infections requiring intravenous antibiotics
Have an ongoing or active infection. The requirement for intravenous (IV) antibiotics is considered active infection.
Serious infection requiring treatment with intravenous antibiotics at the time of study entrance, or an infection requiring intravenous therapy within 7 days prior to the first dose of study treatment.
Receipt of intravenous (IV) antibiotics for infection within 7 days prior to enrollment into the study
Patients with active infection and requiring intravenous (IV) or oral antibiotics
Infection requiring intravenous antibiotics within 14 days before the first dose of study drug
Concurrent severe and/or uncontrolled medical disease including, but not limited to, ongoing or active infection requiring intravenous antibiotics, bowel obstruction
Concurrent severe and/or uncontrolled medical disease including, but not limited to, ongoing or active infection requiring intravenous antibiotics
Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection requiring intravenous antibiotics
Serious, active infections requiring treatment with intravenous (IV) antibiotics
Active infection, uncontrolled with intravenous antibiotics
Patients with active infection requiring intravenous (IV) antibiotics within 2 weeks of registration
Active systemic infections requiring intravenous antibiotics
Active serious infection not controlled by oral or intravenous antibiotics
Patients have an active infection and require intravenous (IV) or oral antibiotics
Active infection requiring intravenous antibiotics
Active infection requiring intravenous (IV) antibiotics
Any uncontrolled active systemic infection that requires treatment with intravenous (IV) antibiotics
Presence of an infection that requires intravenous antibiotics
Active infection requiring intravenous antibiotics.
Current acute infection requiring intravenous antibiotics
Uncontrolled medical illness such as infection requiring intravenous antibiotics
Active infection requiring intravenous (IV) antibiotics
Known active infection requiring intravenous (IV) or oral anti-infective treatment
History of any infection requiring hospitalization or intravenous antibiotics within 2 weeks before enrollment.
The patient has received intravenous administration of antibiotics within 2 weeks prior to first study treatment or oral antibiotics within 1 week prior to first study treatment.
Active systemic infections requiring intravenous antibiotics
Use of intravenous antibiotics within the last 6 months
Serious concomitant medical condition that could interfere with the conduct of the clinical trial, such as unstable angina, renal failure requiring hemodialysis, or active infection requiring intravenous (IV) antibiotics
Diagnosis of an infection requiring intravenous (IV) antibiotics 14 days prior to registration
Active systemic infection requiring ongoing intervention, including but not limited to oral and intravenous antibiotics, anti-fungals, anti-parasites, anti-virals
Active infection requiring oral or intravenous antibiotics
The participant has an active infection (requiring intravenous [IV] antibiotics), including tuberculosis.
